You are assessing a 10-year-old child with apparent ventricular tachycardia, but cannot decide whether electrical or pharmacologic therapy is the most appropriate initial treatment approach. Which of the following interventions would pose the greatest potential for harm?

Prepare for pediatric emergencies with our comprehensive test. Access a wide range of questions, flashcards, and detailed explanations. Master each section and be fully prepared to tackle real-life scenarios with confidence!

Multiple Choice

You are assessing a 10-year-old child with apparent ventricular tachycardia, but cannot decide whether electrical or pharmacologic therapy is the most appropriate initial treatment approach. Which of the following interventions would pose the greatest potential for harm?

Explanation:
In pediatric ventricular tachycardia, the priority is rapid stabilization with the most effective therapy for the patient’s current state. If there’s poor perfusion or the rhythm is hemodynamically unstable, the fastest, most definitive intervention is immediate defibrillation. Pharmacologic therapy is considered when a patient is stable enough to tolerate it, but it should not overshadow or delay electrical treatment if instability is suspected. Starting an IV and then giving two antiarrhythmics in sequence—amiodarone followed by procainamide—poses the greatest risk because both drugs can prolong the QT interval and raise the chance of dangerous proarrhythmias like torsades de pointes. This combination also risks unpredictable hemodynamic effects and delay of potentially life-saving electrical therapy. By delaying defibrillation or definitive electrical management, this approach increases the likelihood of deterioration. Initiating external pacing or using lidocaine first carries comparatively less immediate harm in this uncertain scenario, and defibrillation remains the most urgent option when instability is present.

In pediatric ventricular tachycardia, the priority is rapid stabilization with the most effective therapy for the patient’s current state. If there’s poor perfusion or the rhythm is hemodynamically unstable, the fastest, most definitive intervention is immediate defibrillation. Pharmacologic therapy is considered when a patient is stable enough to tolerate it, but it should not overshadow or delay electrical treatment if instability is suspected.

Starting an IV and then giving two antiarrhythmics in sequence—amiodarone followed by procainamide—poses the greatest risk because both drugs can prolong the QT interval and raise the chance of dangerous proarrhythmias like torsades de pointes. This combination also risks unpredictable hemodynamic effects and delay of potentially life-saving electrical therapy. By delaying defibrillation or definitive electrical management, this approach increases the likelihood of deterioration.

Initiating external pacing or using lidocaine first carries comparatively less immediate harm in this uncertain scenario, and defibrillation remains the most urgent option when instability is present.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy